PubMedDate not supplied
The authors treated 228 asthmatic children during a period of 3 years using a randomised scheme. After a short eliminatory trial the choice of preventive treatment was selected randomly using the patient's registration number. Four groups were formed: Hyposensitization, ACTH, DSCG and Ketotifen (Zaditen). Two thirds of the patients ameliorated in each group. According to the subjective opinion of the parents, 30-33% of the patients became symptomfree on each regimen. This figure was 50% in the hyposensitization and ACTH groups (13%). Serious asthma cases with more than 10 attacks in a year improved, mainly after DSCG or Ketotifen (Zaditen) therapy. The evaluation according to a symptom score and pulmonary function test shows definite amelioration in the groups chemoprophylactic drugs. After a change from the original therapy because of a failure, ACTH and Zaditen were the most successful second drug.
Adrenocorticotropic Hormone↗